Novel compounds of the general formula: ##STR1## and pharmaceutically acceptable acid addition salts thereof, wherein the compounds are useful in therapy to protect skeletal muscles against damage resulting from trauma or to protect skeletal muscles subsequent to muscle or systemic diseases such as intermittent claudication, to treat shock conditions, to preserve donor tissue and organs [...]
Posts Tagged ‘patent’
US Patent #6180615: Propargyl Phenyl Ether A2A Receptor Agonists
2-adenosine propargyl phenyl ether compositions having the following formula: ##STR1## and methods for using the compositions as A.sub.2A receptor agonists to stimulate mammalian coronary vasodilatation for therapeutic purposes and for purposes of imaging the heart.
Granted by the US Patent Office June 22, 1999 ⇒
US Patent #6677336: Substituted Piperazine Compounds
Novel compounds of the general formula: ##STR1## and pharmaceutically acceptable acid addition salts thereof, wherein the compounds are useful in therapy to protect skeletal muscles against damage resulting from trauma or to protect skeletal muscles subsequent to muscle or systemic diseases such as intermittent claudication, to treat shock conditions, to preserve donor tissue and organs [...]